Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine.

This research examined the impact of vatinoxan on heart, respiratory, and digestive functionality in horses under anesthesia, discovering its potential to induce hypotension and a need for further study.

Research Context and Aim

• The study revolves around the administering of medetomidine through CRI (constant rate infusion) to balance inhalation anesthesia in horses. While this process is common, its cardiovascular side effects are a cause for concern.
• The research intended to assess the responses, particularly cardiovascular, respiratory, and gastrointestinal, to vatinoxan, a peripheral α2-adrenoceptor antagonist, in horses under anesthesia.

Methodology

• Six horses were utilized for the experiment. Each was administered either medetomidine alone (referred to as MED) or in combination with vatinoxan (referred to as MED+V).
• Midazolam and ketamine were used to induce anesthesia, which was maintained with isoflurane and medetomidine CRI for an hour.
• Cardiac indices such as heart rate, carotid and pulmonary arterial pressures, central venous pressure, cardiac output, and blood gas levels were meticulously measured. Additional certain cardiopulmonary parameters were computed.
• Plasma concentrations of the drugs and fecal output over 24 hours were tracked and analyzed.

Results

• An observed decrease in heart rate from the baseline was noted in the MED group, while arterial blood pressure declined in both groups.
• To maintain normal blood pressure, significantly more of the drug dobutamine was required in the MED+V group (P=0.018).
• Cardiac index (CI) and oxygen delivery index (DOI) had a significantly greater decrease in the MED group, with the biggest disparity noted at the 20-minute mark.
• No noticeable difference in fecal output or plasma concentrations of dexmedetomidine between the treatment groups.

Conclusions

• The key conclusion drawn from the investigation is that vatinoxan, as a premedication, triggered hypotension, which implies that its application in anesthetized horses may require more comprehensive study.
• While heart rate and arterial blood pressures remained within clinically acceptable limits in the MED group, the cardiac output and oxygen delivery were less optimal than in the MED+V group.